Clinical Guest Contributors

1. What ChatGPT Ads Will Really Mean For Clinical Trials 2/10/2026

   AI health assistants may be used to surface clinical trials earlier in patient journeys, and advertising inside conversational AI is best understood as the next logical step in that same progression.

2. The FDA Calls For Culturally-Informed Research, But What Do We Understand About The Sikh Community? 2/9/2026

   Despite the size and visibility of the community — and the call for diverse patient research — there remains a gap in available health data specific to the Sikh community in the U.S.

3. The Key Role Of Clinical Supply Teams In Patient Centricity Efforts 2/9/2026

   Clinical supply decisions shape patient access, safety, and trial success. From logistics to procurement, patient-centric supply can accelerate therapies or quietly delay them.

4. Pharma Procurement Can Make Or Break Startups: Let's Help Mature Our Future Partners To Secure Innovation 2/6/2026

   To secure long-term innovation, Ascendis Pharma's Ivanna Rosendal suggests pharma companies should help startup companies through their growing pains.

5. Becoming A Backbone Therapy: Lessons Learned With Actuate Therapeutics 2/5/2026

   CEO Dan Schmitt discusses the pursuit of a backbone therapy and how Actuate's current and planned trials are structured to confirm that potential.

6. Building Patient Trust In Research Through Connection Driven-Transparency 2/4/2026

   The question is not whether trust matters but how industry, sponsors, and investigators can bridge the trust gap to drive patient participation.

7. How To Lead A Moonshot Collaboration: Lessons From Over A Decade Of Competitors Working Together 2/3/2026

   TransCelerate BioPharma's Andy Lee and Janice Change share the lessons they learned bringing disparate voices together for a united purpose.

8. Patient Trust In Pharma Is Low; Here's How To Rebuild It 2/2/2026

   CISCRP's Annick de Bruin and Shalome Sine provide strategies for building patient trust based on the findings from their Perceptions & Insights Study.

9. The U.S. Trial Advantage Is Eroding 1/30/2026

   Once the go-to location for trials, the U.S. is now seeing competition from APAC, driven by political, economic, and workforce pressures domestically and rapid growth abroad.

10. Making AI Safety Routine: How Sites And Sponsors Can Continuously Monitor Clinical AI 1/29/2026

    Learn why the next frontier in AI governance will involve real-time surveillance of algorithmic performance across institutions with guidance from Akshaya Bhagavathula and Michelle A. Williams.